ACAT1 deletion in murine macrophages associated with cytotoxicity and decreased expression of collagen type 3A1

Biochemical and Biophysical Research Communications

Volumn 331, Issue 1, 2005, Pages 61-68

  Rodriguez, Annabelle ^a   Ashen, M Dominique ^b   Chen, Edward S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

ACAT; Atherosclerosis; Cytotoxicity; Foam cells

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ADENINE; CARBON 14; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 3A1; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL SECRETION; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; FEMALE; FOAM CELL; GENE DELETION; GENE FUNCTION; HOMOGENATE; KNOCKOUT GENE; LIPID ANALYSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 17444427065     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.126     Document Type: Article

References (43)

1. R. Ross The pathogenesis of atherosclerosis: an update N. Engl. J. Med. 314 1986 488 500
2. M.S. Brown, Y.K. Ho, and J.L. Goldstein The cholesteryl ester cycle in macrophage foam cells J. Biol. Chem. 255 1980 9344 9352
3. K.F. Buhmamn, M. Accad, and R.V. Farese Jr. Mammalian acyl-CoA:cholesterol acyltransferases Biochim. Biophys. Acta 1529 2000 142 154
4. H.T. Lee, D.R. Sliskovic, J.A. Picard, B.D. Roth, W. Wieranga, J.L. Hicks, R.F. Bousley, K.L. Hamelehle, R. Homan, C. Speyer, R.L. Stanfield, and B. Krause Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents J. Med. Chem. 39 1996 5031 5034
5. A. Rodriguez, P.S. Bachorik, and S.-B. Wee Novel effects of the acyl-coenzyme A:cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages Arterioscler. Thromb. Vasc. Biol. 19 1999 2199 2206
6. A. Rodriguez, and D.C. Usher Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages Atherosclerosis 161 2002 45 54
7. G.J. Warner, G. Stoudt, M. Bamberger, W.J. Johnson, and G.H. Rothblat Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol J. Biol. Chem. 270 1995 5772 5778
8. V.L. Meiner, S. Cases, H.M. Myers, E.R. Sande, S. Bellosta, M. Schambelan, R.E. Pitas, J. McGuire, J. Herz, and R.V. Farese Jr. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals Proc. Natl. Acad. Sci. USA 93 1996 14041 14046
9. T.T. Ishikawa, J. MacGee, J.A. Morrison, and C.J. Glueck Quantitative analysis of cholesterol in 5 to 20 microliters of plasma J. Lipid Res. 15 1974 286 291
10. M.K. Markwell, S.M. Haas, L.L. Bieber, and N.E. Tolbert A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples Anal. Biochem. 87 1978 206 210
11. V.C. Reid, C.E. Brabbs, and M.J. Mitchinson Cellular damage in mouse peritoneal macrophages exposed to cholesteryl linoleate Atherosclerosis 92 1992 251 260
12. V. Shirhatti, and G. Krishna A simple and sensitive method for monitoring drug-induced cell injury in cultured cells Anal. Biochem. 147 1985 410 418
13. J. Luo, D.J. Duggan, Y. Chen, J. Sauvageot, C.M. Ewing, M.L. Bittner, J.M. Trent, and W.B. Isaacs Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling Cancer Res. 61 2001 4683 4688
14. A. Lopez-DeLeon, and M. Rojkind A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections J. Histochem. Cytochem. 33 1985 737 743
15. M. Huang, S. Sharma, L.X. Zhu, M.P. Keane, J. Luo, L. Zhang, M.D. Burdick, Y.Q. Lin, M. Dohadwala, B. Gardner, R.K. Batra, R.M. Strieter, and S.M. Dubinett IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis J. Clin. Invest. 109 2002 931 937
16. G. Kellner-Weibel, S.J. Luke, and G.H. Rothblat Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1 Atherosclerosis 171 2003 235 243
17. D.J.M. Delsing, E.H. Offerman, W. van Duyvenvoorde, H. van Der Boom, E.C. de Wit, M.J. Gijbels, A. van Der Laarse, J.W. Jukema, L.M. Havekes, and H.M. Princen Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in apoE3-Leiden mice Circulation 103 2001 1778 1786
18. J. Kusunoki, D.K. Hansoty, K. Aragane, J.T. Fallon, J.J. Badimon, and E.A. Fisher Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 103 2001 2604 2609
19. T.M.A. Bocan, S.B. Mueller, E.Q. Brown, P. Lee, M.J. Bocan, T. Rea, and M.E. Pape HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit Atherosclerosis 139 1998 21 30
20. R.J. Nicolosi, T.A. Wilson, and B.R. Krause The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters Atherosclerosis 137 1998 77 85
21. T. Chiwata, K. Aragane, K. Fujinami, K. Kojima, S. Ishibashi, N. Yamada, and J. Kusunoki Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice Br. J. Pharmacol. 133 2001 1005 1012
22. S. Perrey, C. Legendre, A. Matsuura, C. Guffroy, J. Binet, S. Ohbayashi, T. Tanaka, J.C. Ortuno, T. Matsukura, T. Laugel, P. Padovani, F. Bellamy, and A.D. Edgar Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis Atherosclerosis 155 2001 359 370
23. G. Kellner-Weibel, Y.J. Geng, and G.H. Rothblat Cytotoxic cholesterol is generated by the hydrolysis of cytoplasmic cholesteryl ester and transported to the plasma membrane Atherosclerosis 146 1999 309 319
24. G. Kellner-Weibel, W.G. Jerome, D.M. Small, G.J. Warner, J.K. Stoltenborg, M.A. Kearney, M.H. Corjay, M.C. Phillips, and G.H. Rothblat Effects of intracellular free cholesterol accumulation on macrophage viability Arterioscler. Thromb. Vasc. Biol. 18 1998 423 431
25. M. Accad, S.J. Smith, D.L. Newland, D.A. Sanan, L.E. King, M.F. Linton, S. Fazio, and R.V. Farese Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1 J. Clin. Invest. 105 2000 711 719
26. H. Yagyu, T. Kitamine, J. Osuga, R. Tozawa, Z. Chen, Y. Kaji, T. Oka, S. Perrey, Y. Tamura, K. Ohashi, H. Okazaki, N. Yahagi, F. Shionoiri, Y. Iizuka, K. Harada, H. Shimano, H. Yamashita, T. Gotoda, N. Yamada, and S. Ishibashi Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia J. Biol. Chem. 275 2000 21324 21330
27. S. Fazio, A.S. Major, L.L. Swift, L.A. Gleaves, M. Accad, M.F. Linton, and R.V. Farese Jr. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages J. Clin. Invest. 107 2001 163 171
28. W. Insull, M. Koren, J. Davignon, D. Sprecher, H. Schrott, L.M. Keilson, A.S. Brown, C.A. Dujovne, M.H. Davidson, R. McLain, and T. Heinonen Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins in patients with combined hyperlipidemia Atherosclerosis 157 2001 137 144
29. G. Kellner-Weibel, P.G. Yancey, W.G. Jerome, T. Walser, R.P. Mason, M.C. Phillips, and G.H. Rothblat Crystallization of free cholesterol in model macrophage foam cells Arterioscler. Thromb. Vasc. Biol. 19 1999 1891 1898
30. B. Feng, P.M. Yao, Y. Li, C.m. Devlin, D. Zhang, H.P. Harding, M. Sweeney, J.X. Rong, G. Kuriakose, E.A. Fisher, A.R. Marks, D. Ron, and I. Tabas The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages Nat. Cell Biol. 5 2003 781 792
31. P.M. Yao, and I. Tabas Free cholesterol loading of macrophages induces apoptosis involving the Fas pathway J. Biol. Chem. 275 2000 23807 23813
32. G. Lipowsky, F.R. Bishcoff, P. Schwarzmaier, R. Kraft, S. Kostka, E. Hartmann, U. Kutay, and D. Gorlich Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes EMBO J. 19 2000 4362 4371
33. A.H. Campos, W. Wang, M.J. Pollman, and G.H. Gibbons Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation Circ. Res. 91 2002 999 1006
34. K. Nomaguchi, S. Suzu, M. Yamada, H. Hayasawa, and K. Motoyoshi Expression of Jagged1 gene in macrophages and its regulation by hematopoietic growth factors Exp. Hematol. 29 2001 850 855
35. V. Lindner, C. Booth, I. Prudovsky, D. Small, T. Maciag, and L. Liaw Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell-matrix and cell-cell interactions Am. J. Pathol. 159 2001 875 883
36. S.E. Bell, A. Mavila, R. Salazar, K.J. Bayless, S. Kanagala, S.A. Maxwell, and G.E. Davis Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling J. Cell Sci. 114 2001 2755 2773
37. C.H. Ding, Q. Li, Z.Y. Xiong, A.W. Zhou, G. Jones, and S.Y. Xu Oral administration of type II collagen suppresses pro-inflammatory mediator production of synoviocytes in rats with adjuvant arthritis Clin Exp Immunol 132 2003 416 423
38. S. Schmoelzl, S.J. Benn, J.E. Laithwaite, S.J. Greenwood, W.S. Marshall, N.A. Munday, D.J. FitzGerald, and J. LaMarre Expression of hepatocyte low-density lipoprotein receptor-related protein is post-transcriptionally regulated by extracellular matrix Lab. Invest. 78 1998 1405 1413
39. E.F. Rocnik, E. van der Veer, H. Cao, R.A. Hegele, and J.G. Pickering Functional linkage between the endoplasmic reticulum protein Hsp47 and procollagen expression in human vascular smooth muscle cells J. Biol. Chem. 277 2002 38571 38578
40. J. Rosenbloom, B. Saitta, S. Gaidarova, N. Sandorfi, J.C. Rosenbloom, W.R. Abrams, A.D. Hamilton, S.M. Sebti, U. Kucich, and S.A. Jimenez Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyltransferase I Arthritis Rheum. 43 2000 1624 1632
41. U. Kucich, J.C. Rosenbloom, G. Shen, W.R. Abrams, A.D. Hamilton, S.M. Sebti, and J. Rosenbloom TGF-β1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyltransferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-δ, and p38, but not erk1/erk2 Arch. Biochem. Biophys. 374 2000 313 324
42. U. Kuchich, J.C. Rosenbloom, G. Shen, W.R. Abrams, M.A. Blaskovich, A.D. Hamilton, J. Ohkanda, S.M. Sebti, and J. Rosenblood Requirement for geranylgeranyltranferase I and acyl transferase in the TGF-β-stimulated pathway leading to elastin mRNA stabilization Biochem. Biophys. Res. Commun. 252 1998 111 116
43. D.E. Dove, Y.R. Su, W. Zhang, W.G. Jerome, L.L. Swift, M.R. Linton, and S. Fazio ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages Arterioscler. Thromb. Vasc. Biol. 25 2005 128 134